personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
In our cover feature, we examine pharma’s relationship with AI and how these platforms could transform R&D and the business landscape. Meanwhile in "In My View", experts share their perspectives on digitalization, the importance of choosing the right technologies for bioprocessing, and more. We ask members of our 2021 Power List what the industry can learn from COVID-19 in “Business”, and we also find out how the UK’s biotechnology sector is looking to plug a skills gap by attracting a wave of new professionals to the industry. When it comes to next generation technologies, Lorna Ewart from Emulate explains how organ-on-chip technologies can be used to accelerate clinical development. Finally, we sit down with G-CON’s Maik Jornitz who walks us through the most surprising changes he’s witnessed during his time in industry.